MARCIA UCHOA DE REZENDE
Projetos de Pesquisa
Unidades Organizacionais
Instituto de Ortopedia e Traumatologia, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/41 - Laboratório de Investigação Médica do Sistema Músculoesquelético, Hospital das Clínicas, Faculdade de Medicina
LIM/41 - Laboratório de Investigação Médica do Sistema Músculoesquelético, Hospital das Clínicas, Faculdade de Medicina
6 resultados
Resultados de Busca
Agora exibindo 1 - 6 de 6
- BRAZILIAN CONSENSUS STATEMENT ON VISCOSUPPLEMENTATION OF THE HIP (COBRAVI-Q)(2022) SOUSA, Eduardo Branco De; HAMDAN, Paulo Cesar; MENEGASSI, Zartur Jose Barcelos; ALCHAAR, Adrieni Antunes Do Amaral; TIEPPO, Antonio Martins; SOUZA, Caio Goncalves De; PINHEIRO, Carlos Bruno Reis; ALMEIDA, Cyro Scala De; ROCHA, Eduardo De Melo Carvalho; CUNHA, Fabiano Goncalves; PACHECO, Ivan; REZENDE, Marcia Uchoa De; SOUZA, Marcio Passini Goncalves De; SILVA, Marcos Britto Da; CAMPOS, Gustavo Constantino DeObjective: The Brazilian Consensus on Hip Viscosupplementation aims to generate a referential and consensual source from the theoretical knowledge and clinical experience of specialists in the field. Methods: A multidisciplinary panel was formed with 15 specialists (sports medicine, orthopedists, physiatrists and rheumatologists), based on clinical and academic experience in the use of viscosupplementation of the hip. 12 statements were prepared, discussed and voted. Each panelist gave a value between 0 and 10 on a Likert scale, specifying their level of agreement with the statement. Results: The panel reached a consensus on several aspects of viscosupplementation of the hip, with emphasis on the following statements: best indication is for mild to moderate hip arthrosis; it may be indicated in severe osteoarthritis; results may vary according to the characteristics of the viscosupplement used; Viscosupplementation should not be performed as an isolated procedure, but in conjunction with other rehabilitation and pharmacological measures; best injection technique should be based on anatomical references coupled with imaging guidance; it is a cost-effective procedure. Conclusion: Viscosupplementation is a safe and effective therapy for hip osteoarthritis, even in severe cases. Guided injection is recommended.
conferenceObject EFFECTS OF KNEE OSTEOARTHRITIS SELF-MANAGEMENT PROGRAM (PARQVE) AFTER TWO YEARS OF USUAL CARE(2022) REZENDE, M.; OCAMPOS, G.; AROUCA, M.; CAMARGO, P.- SELF-MANAGEMENT PROGRAM (PARQVE) IMPROVES QUALITY OF LIFE IN SEVERE KNEE OSTEOARTHRITIS(2022) BISCARO, Raphael carvalho; OCHOA, Pablo gabriel garcia; OCAMPOS, Guilherme pereira; AROUCA, Matheus manolo; CAMARGO, Olavo pires de; REZENDE, Marcia Uchoa deObjective: To evaluate the effects of the self-management program PARQVE in patients with severe knee osteoarthritis (KOA). Methods: Prospective randomized controlled clinical trial with 65 grade IV Kelgren & Lawrence (K & L) KOA patients who were allocated into groups: Control (CG) and Intervention (IG). Both groups received usual care. IG also participated in two days of multi-professional interventions about OA (causes and treatment) and received the program's DVD and book. Standing X-rays were obtained at inclu-sion and Ahlback's classification was registered. Western Ontario and McMaster Universities Index (WOMAC), Numerical Rating Scale (NRS), Lequesne, weight, and body mass index (BMI) were obtained at inclusion, and after 6, 12 and 24 months. Results: Groups were similar at baseline, despite higher WOMAC stiffness scores and a greater number of Ahlback's grade 4 and 5 in the IG. Only the IG improved WOMAC and total functions (p < 0.001) during the study period above 12%, but did not reach the minimal clinically important difference of 20%. Best results were in one year. Non-significant improvements were observed without changes in body composition (P > 0.05). Conclusions: Patients with severe KOA have mild to moderate function and quality of life improvement due to self-management program (PARQVE).
conferenceObject FOUR-YEAR RESULTS OF KNEE OSTEOARTHRITIS SELF-MANAGEMENT PROGRAM (PARQVE)(2022) REZENDE, M.; OCAMPOS, G.; AROUCA, M.; CAMARGO, P.- EVALUATION OF MANAGEMENT OF PATIENTS WITH OSTEOPOROTIC FRACTURES BY ORTHOPEDIC RESIDENTS: A CROSS-SECTIONAL OBSERVATIONAL STUDY(2022) OCAMPOS, Guilherme pereira; PERES, Matheus Mendonca; REZENDE, Marcia Uchoa de; AROUCA, Matheus Manolo; CAMARGO, Olavo Pires deObjective: To assess whether residents (R1, R2, or R3 -according to the year of residency) of a tertiary orthopedic service inves-tigate, treat and/or refer the patient with osteoporotic fracture for osteoporosis (OP) treatment and whether this learning is improved over the years of residency. Methods: Residents answered diagnostic and therapeutic questions related to a clinical case of osteoporotic fracture (OF) in 4 settings, which were initial care in the emergency room, at discharge, during out-patient follow-up at 3 and 6 months. Responses were compared between years of residency. Results: Twenty R1, 21 R2, and 19 R3 raised the questions. One resident treated osteoporosis in R1, two in R2, and four in R3. Seventy-five percent of R1, 90.5% of R2, and 68% of R3 referred patients for OP treatment. Over the years, there has been improved prescribing lab tests for osteoporosis (p = 0.028), with 52.6% of third-year residents prescribing adequate lab tests. In the same period, 100% of R3 correctly prescribed prophylaxis for deep vein thrombosis (p = 0.001). Conclusion: There is learning, but not enough, for secondary prevention of FO. Level of Evidence I; Prospective Comparative Study.
- Pilot study of the effect of therapeutic photobiomodulation on postoperative pain in knee arthroplasty(2022) REZENDE, Marcia Uchoa de; VARONE, Bruno Butturi; MARTUSCELLI, Diego Ferreira; OCAMPOS, Guilherme Pereira; FREIRE, George Miguel Goes; PINTO, Nathali Cordeiro; SOUSA, Marcelo Victor Pires deAbstract Nine participants undergoing primary TKA submitted to spinal anesthesia, sedation, ultrasound-guided obturator and Femoral nerve Block analgesia, and photobiomodulation Therapy (FBMT) were evaluated regarding postoperative pain and morphine consumption. FBMT sessions were performed in the Immediate Postoperative period (IPO) and after 24 hours. Participants received 16.7±15 mg of morphine up to the third postoperative day. At IPO, mean pain score was 4.8 ± 3.2 and 5.6 ± 3.5, at rest and on movement, respectively. Photo biomodulation therapy can be considered an option for mitigating pain for patients undergoing TKA.